A Hidden Cancer, Found in Time: One Patient’s CARE Journey

The CARE Difference: A Smarter Workflow for High‑Risk Screening

Making Waves with MAVES
Post Image

A Hidden Cancer, Found in Time: One Patient’s CARE Journey
  • Frankie Fann, MS, CGC
  • April 9, 2026

Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge opens the door to proactive screening and early detection, when cancers may be easier to treat. By routinely assessing which patients may be at increased hereditary risk, …

Read More
Post Image

The Gene Scene: GAA

  • April 7, 2026
Post Image

The CARE Difference: A Smarter Workflow for High‑Risk Screening

  • March 25, 2026
Post Image

The Gene Scene: SMAD4

  • March 24, 2026
Post Image

The Gene Scene: CASQ2

  • March 17, 2026
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience
  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More
Post Image

Navigating NF1: The Moss Family’s Story of Resilience and Hope

  • May 16, 2024
Post Image

Transforming Fear into Action and Advocacy: Our Family’s Lynch Syndrome Story

  • March 22, 2024
Post Image

Peace of Mind: Michelle Majewski Trusts the Patient for Life Program to Share Answers for Her Son Owen

  • November 14, 2023
Post Image

Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week

  • June 14, 2023

Subscribe

Subscribe to our blog for updates, sent out every month.

Tags